Published in AIDS on July 17, 2013
HIV self-testing among online MSM in China: implications for expanding HIV testing among key populations. J Acquir Immune Defic Syndr (2014) 1.19
Arguments for and against HIV self-testing. HIV AIDS (Auckl) (2014) 1.01
HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J Am Pharm Assoc (2003) (2014) 0.98
HIV self-testing could "revolutionize testing in South Africa, but it has got to be done properly": perceptions of key stakeholders. PLoS One (2015) 0.95
HIV self-testing among key populations: an implementation science approach to evaluating self-testing. J Virus Erad (2015) 0.93
Anticipated and actual reactions to receiving HIV positive results through self-testing among gay and bisexual men. AIDS Behav (2014) 0.90
What are the constraints and opportunities for HIVST scale-up in Africa? Evidence from Kenya, Malawi and South Africa. J Int AIDS Soc (2015) 0.90
Benefits and Potential Harms of Human Immunodeficiency Virus Self-Testing Among Men Who Have Sex With Men in China: An Implementation Perspective. Sex Transm Dis (2017) 0.89
Experiences and correlates of HIV self-testing among men who have sex with men in Jiangsu province, China. AIDS Behav (2015) 0.86
Missed opportunities for HIV screening in pharmacies and retail clinics. J Manag Care Spec Pharm (2014) 0.85
"Just Because It's Out There, People Aren't Going to Use It." HIV Self-Testing Among Young, Black MSM, and Transgender Women. AIDS Patient Care STDS (2015) 0.80
Routine HIV Screening in an Urban Community Health Center: Results from a Geographically Focused Implementation Science Program. Public Health Rep (2016) 0.80
Home HIV testing: if you build it, will they come? AIDS (2013) 0.79
Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual men. BMC Infect Dis (2015) 0.79
Swab2know: An HIV-Testing Strategy Using Oral Fluid Samples and Online Communication of Test Results for Men Who Have Sex With Men in Belgium. J Med Internet Res (2015) 0.78
Public readiness for HIV self-testing in Kenya. AIDS Care (2016) 0.78
HIV test uptake among MSM in China: Implications for enhanced HIV test promotion campaigns among key populations. Glob Public Health (2016) 0.77
The Potential for HIV Self-testing in Iran. Int J Prev Med (2015) 0.75
Consolidating emerging evidence surrounding HIVST and HIVSS: a rapid systematic mapping protocol. Syst Rev (2017) 0.75
Does a Video Improve Knowledge of HIV/AIDS and HIV Testing among a Global Internet Audience? J Int Assoc Provid AIDS Care (2015) 0.75
Knowledge and use of unauthorized HIV self-test kits among men who have sex with men in Spain, following approval of an over-the-counter self-test in the U.S: a cross-sectional study. BMC Public Health (2016) 0.75
eTEST: Developing a Smart Home HIV Testing Kit that Enables Active, Real-Time Follow-Up and Referral After Testing. JMIR Mhealth Uhealth (2017) 0.75
Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention: Results from the HPTN 065 Study. J Int Assoc Provid AIDS Care (2016) 0.75
Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection. J Int AIDS Soc (2017) 0.75
"I think it is right": a qualitative exploration of the acceptability and desired future use of oral swab and finger-prick HIV self-tests by lay users in KwaZulu-Natal, South Africa. BMC Res Notes (2017) 0.75
Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21
Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med (2011) 5.31
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS (2006) 4.23
Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses (2006) 3.74
Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS (2006) 3.70
Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA (2008) 3.61
Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med (2010) 3.27
Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis (2002) 3.11
When to start ART in Africa--an urgent research priority. N Engl J Med (2013) 3.07
Results of a rapid HIV screening and diagnostic testing program in an urban emergency department. Ann Emerg Med (2008) 3.07
Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. J Acquir Immune Defic Syndr (2003) 3.00
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med (2007) 2.93
Rapid HIV-1 testing during labor: a multicenter study. JAMA (2004) 2.81
Prevalence of undiagnosed HIV infection among persons aged ≥13 years--National HIV Surveillance System, United States, 2005-2008. MMWR Morb Mortal Wkly Rep (2012) 2.52
Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr (2007) 2.48
Choosing HIV Counseling and Testing Strategies for Outreach Settings: A Randomized Trial. J Acquir Immune Defic Syndr (2005) 2.36
A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS (2006) 2.34
Antiretroviral therapy for the prevention of HIV transmission: what will it take? Clin Infect Dis (2014) 2.14
Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned. Clin Infect Dis (2010) 2.10
Cost comparison of three HIV counseling and testing technologies. Am J Prev Med (2003) 2.06
The HIV care continuum: no partial credit given. AIDS (2012) 1.87
Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Health (2011) 1.85
Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS One (2007) 1.80
Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus Initiative. Reprod Health Matters (2005) 1.77
Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. Am J Obstet Gynecol (2007) 1.74
Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis (2011) 1.69
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Keeping health facilities safe: one way of strengthening the interaction between disease-specific programmes and health systems. Trop Med Int Health (2010) 1.66
Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol (2003) 1.66
Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials (2008) 1.65
HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med (2013) 1.59
Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr (2005) 1.56
Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population. J Clin Virol (2011) 1.52
Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS (2005) 1.51
Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS One (2012) 1.46
Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis (2010) 1.46
Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS (2004) 1.42
Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine. J Acquir Immune Defic Syndr (2005) 1.42
Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics. MedGenMed (2007) 1.41
Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt) (2008) 1.40
Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Rep (2009) 1.39
CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr (2010) 1.35
The impact of HIV scale-up on health systems: A priority research agenda. J Acquir Immune Defic Syndr (2009) 1.33
Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr (2011) 1.32
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Ann Intern Med (2012) 1.32
Detection of acute HIV infection: we can't close the window. J Infect Dis (2011) 1.32
Game changers: why did the scale-up of HIV treatment work despite weak health systems? J Acquir Immune Defic Syndr (2011) 1.28
HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS (2012) 1.28
Reproductive decisions in HIV-infected individuals. Lancet (2005) 1.27
Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr (2010) 1.27
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials. HIV Clin Trials (2006) 1.27
Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy. J Acquir Immune Defic Syndr (2007) 1.25
Rapid HIV antibody testing in the New York State Anonymous HIV Counseling and Testing Program: experience from the field. J Acquir Immune Defic Syndr (2006) 1.24
Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS (2004) 1.22
Antiretroviral therapy for prevention is a combination strategy. Curr HIV/AIDS Rep (2013) 1.21
Routine HIV screening in two health-care settings--New York City and New Orleans, 2011-2013. MMWR Morb Mortal Wkly Rep (2014) 1.21
Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. AIDS (2010) 1.19
Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa. PLoS One (2012) 1.19
Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther (2005) 1.14
Designing an HIV counseling and testing program for bathhouses: the Seattle experience with strategies to improve acceptability. J Homosex (2003) 1.14
Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis (2011) 1.13
HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr (2013) 1.11
Antiretroviral therapy: a promising HIV prevention strategy? J Acquir Immune Defic Syndr (2010) 1.11
Rapid HIV testing. Wait time reduced from days to minutes. Postgrad Med (2005) 1.04
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr (2014) 1.01
The Nursing Education Partnership Initiative (NEPI): innovations in nursing and midwifery education. Acad Med (2014) 1.01
Use of HIV case surveillance system to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065. Open AIDS J (2012) 1.00
Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS (2008) 1.00
HIV screening in the health care setting: status, barriers, and potential solutions. Mayo Clin Proc (2012) 0.98
Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS (2013) 0.98
Advancing HIV prevention demonstration projects: new strategies for a changing epidemic. Public Health Rep (2009) 0.95
Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations. AIDS (2008) 0.92
Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections. J Clin Virol (2011) 0.91
'Men usually say that HIV testing is for women': gender dynamics and perceptions of HIV testing in Lesotho. Cult Health Sex (2014) 0.90
HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men. J Acquir Immune Defic Syndr (2012) 0.90
Antiretroviral therapy for prevention of HIV and tuberculosis: a promising intervention but not a panacea. J Acquir Immune Defic Syndr (2013) 0.90
Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART Study. J Acquir Immune Defic Syndr (2016) 0.89
Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments? AIDS (2003) 0.88
HIV screening practices and hospital characteristics in the US, 2009-2010. Public Health Rep (2013) 0.87
HIV screening practices in U.S. hospitals, 2009-2010. Public Health Rep (2012) 0.87
Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries. J Acquir Immune Defic Syndr (2015) 0.87
2010 HIV Diagnostics Conference. Expert Rev Anti Infect Ther (2010) 0.87
Linkage from HIV testing to care: a positive test often leads nowhere. Sex Transm Dis (2013) 0.86
Implementation and Operational Research: Postpartum Transfer of Care Among HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy. J Acquir Immune Defic Syndr (2015) 0.85
Family matters: Co-enrollment of family members into care is associated with improved outcomes for HIV-infected women initiating antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.85
To screen or not to screen: is that really the question? Ann Intern Med (2006) 0.85
Emergency department HIV screening with rapid tests: a cost comparison of alternative models. AIDS Educ Prev (2011) 0.85
A tale of two viruses: HIV, Ebola and health systems. AIDS (2015) 0.84
Acceptability of home self-tests for HIV in New York City, 2006. Am J Public Health (2014) 0.84
Health systems and health equity: the challenge of the decade. Glob Public Health (2012) 0.84
Lessons from Africa. J Acquir Immune Defic Syndr (2010) 0.83
Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis. IRB (2011) 0.82
Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence. PLoS One (2011) 0.82
Re: "Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening". Am J Epidemiol (2012) 0.81
Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Am J Clin Nutr (2005) 0.80
Maternal and infant outcomes with concurrent treatment of tuberculosis and HIV infection in pregnant women. J Acquir Immune Defic Syndr (2011) 0.80